Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 277
Selected: 0
NCT IDTitle
NCT02514694LEO 32731 - A Phase I Study in Healthy Subjects
NCT03363854Tralokinumab in Combination With Topical Corticosteroids for Moderate to Severe Atopic Dermatitis - ECZTRA 3
NCT00216827Efficacy and Safety of Calcipotriol Plus Betamethasone Gel in the Treatment of Scalp Psoriasis
NCT01229098Effect of LEO 80185 Gel on the HPA Axis and Calcium Metabolism in Subjects With Extensive Psoriasis Vulgaris
NCT03331835A Trial Comparing the Efficacy of Subcutaneous Injections of Brodalumab to Oral Administrations of Fumaric Acid Esters in Adults With Moderate to Severe Plaque Psoriasis
NCT01347255A Psoriasis Plaque Test Study With LEO 90100 Cutaneous Spray, Ointment, in Psoriasis Vulgaris
NCT00225108The STOP CLOT Pilot Study: Study of Low Molecular Weight Heparin in High Risk Cesarean Section
NCT03160885Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 2 (ECZema TRAlokinumab Trial no. 2)
NCT03192280Skin IaM: An Exploratory Clinical Trial to Evaluate Changes in Skin Appearance, Colour, and/or Texture Following the Induction of a Local Inflammatory Skin Response
NCT02103725A Multi-Centre Clinical Trial to Evaluate a Left-Right Design in Adults With Mild to Moderate Atopic Dermatitis
NCT02090465Assessment of Treatment Success and Quality of Life in Patients With Actinic Keratoses Under Therapy With Ingenol Mebutate in a Period of 8 Weeks
NCT01850849Safety, Tolerability and Pharmacokinetics in AD Subjects and Healthy Subjects of Cutaneous Application of LEO 39652 Cream
NCT00711308Tinzaparin in the Treatment of the Acute Pulmonary Embolism
NCT01430533Human Repeated Insult Patch Test (HRIPT) of Azelaic Acid Pre Foam Formulation
NCT01083758Safety and Efficacy of LEO 80185 Topical Suspension in Adolescent Subjects (Aged 12 to 17) With Scalp Psoriasis
NCT01037881LEO 29102 Cream in the Treatment of Atopic Dermatitis
NCT01257919Safety and Pharmacokinetics of Azelaic Acid Foam, 15% in Papulopustular Rosacea
NCT05099133A Trial to Evaluate Pharmacokinetics, Immunogenicity, Safety, and Tolerability of LEO 138559 in Healthy Japanese Subjects
NCT04361136Clinical Trial to Evaluate Light-induced Skin Reactions After Application of Delgocitinib Cream
NCT00764751Efficacy and Safety of LEO 19123 Cream in the Treatment of Psoriasis Vulgaris
NCT04871711Efficacy and Safety of Delgocitinib Cream in Adults With Moderate to Severe Chronic Hand Eczema
NCT03569345Basal Cell Carcinomas Treated With Ablative Fractional Laser and Ingenol Mebutate
NCT02636101Xamiol®Gel in BODY Psoriasis: A One-year Non-interventional Study
NCT04765332Evaluation of the Sensitivity and Specificity of a Novel Quality of Life Tool to Assess the Treatment Satisfaction in Psoriasis Patients
NCT01930396Use of Tinzaparin for Anticoagulation in Hemodialysis
NCT00704262Effect of Calcipotriol Plus Hydrocortisone Ointment on the Adrenal Hormone Balance and Calcium Metabolism in Patients With Psoriasis Vulgaris on the Face and Skin Folds
NCT00051532Seocalcitol Versus Placebo in Advanced Hepatocellular Carcinoma
NCT01449513PEP005 Gel - Biological Effects in Actinic Keratosis Assessed by Reflectance Confocal Microscopy
NCT01922050A Study of Increasing Strengths, Safety and Efficacy of Two Formulas of LEO 43204 on the Face or the Chest in Patients With Actinic Keratosis
NCT00403949A Study of Azelaic Acid (AzA) 15% in Topical Treatment of Mild to Moderate Perioral Dermatitis
NCT0143031221 Day Irritancy Test of Azelaic Acid Pre-foam Formulation
NCT03556592Drug-drug Interaction Trial With Tralokinumab in Moderate to Severe Atopic Dermatitis - ECZTRA 4
NCT00417937A Multicenter Trial of a Topical Medication for Papulopustular Rosacea Applied Twice Daily Versus Once Daily
NCT04883333A Single and Multiple Ascending-dose Trial of LEO 153339 in Healthy Adults
NCT05388760Tralokinumab Monotherapy for Children With Moderate-to-severe Atopic Dermatitis - TRAPEDS 1 (TRAlokinumab PEDiatric Trial no. 1)
NCT03725722Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over an 8-week Treatment Period in Adult Subjects With Atopic Dermatitis.
NCT03508856Clinical and Histologic Evaluation of Picato 0.15% Gel in the Cosmetic Improvement of Photoaged Skin
NCT02899962LEO 90100 Twice Weekly Maintenance Regimen for Psoriasis Vulgaris
NCT00506519Recombinant Human Antithrombin (ATryn®) in the Treatment of Patients With DIC Associated With Severe Sepsis
NCT00875277A Psoriasis Plaque Test With LEO 29102 Cream and Its Combination Products
NCT02748902Exploratory Study of Efficacy and Safety of Ingenol Mebutate 0.05% Gel for Common Warts on the Hands.
NCT01268774Preventive Treatment of VETD in Patients With Multiple Myeloma Receiving Chemotherapy With Thalidomide or Lenalinomide.
NCT05259722A 24 Week Trial to Compare the Efficacy and Safety of Delgocitinib Cream 20 mg/g Twice-daily With Alitretinoin Capsules Once-daily in Adult Participants With Severe Chronic Hand Eczema
NCT01141179The Impact of Renal Impairment on the Pharmacokinetic and Pharmacodynamic of LEO 27847
NCT01387711PEP005 Gel - Biological Effects in Actinic Keratosis Assessed by Histology
NCT00855595Efficacy of Topical Azelaic Acid 15% Gel Plus Anti-inflammatory Dose Doxycycline or Metronidazole Gel 1% Plus Anti-inflammatory Dose Doxycycline in Moderate Papulopustular Rosacea
NCT01105234An Irritation Study With New Calcipotriol Ointment Formulations in Healthy Subjects
NCT02376049A Clinical Trial to Compare Topical Agents in Adults With Mild to Moderate Atopic Dermatitis (AD)
NCT00216840Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel in Scalp Psoriasis
NCT03526861Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).